Indication

Zaire ebolavirus vaccination

Zaire ebolavirus vaccination is an active immunization indication directed at the prevention of Ebola virus disease caused specifically by the filovirus species *Zaire ebolavirus* (also classified as *Orthoebolavirus zairense*). Read more about Zaire ebolavirus vaccination

2 drugs 1 manufacturers

Drugs that treat it

Common Zaire ebolavirus vaccination therapies.

Showing 1–2 of 2 drugs

Sort

ERVEBO(PF)(NATIONAL STOCKPILE) (ebola (Zaire) recombinant vaccine, live, vero cell/PF)

EBOLA VACCINE·ZAIRE EBOLAVIRUS VACCINATION

Merck Sharp & Dohme

ERVEBO (NATIONAL STOCKPILE) (ebola (Zaire) recombinant vaccine, live, vero cell/PF)

EBOLA VACCINE·ZAIRE EBOLAVIRUS VACCINATION

Merck Sharp & Dohme

Filter & compare in the drug finder →Opens the drug finder with Zaire ebolavirus vaccination preselected.

News & literature

Coming soon

Related codes

Coming soon

About Zaire ebolavirus vaccination.

The target pathogen causes a severe, high-mortality viral hemorrhagic fever characterized by systemic immune dysregulation, extensive vascular endothelial damage, microvascular permeability, and consumptive coagulopathy.

Clinical manifestations progress rapidly from acute flu-like symptoms to gastrointestinal distress, hypotension, severe multisystem organ failure, and hemorrhagic shock.

Immunization is indicated for individuals at high risk of exposure, including healthcare personnel, laboratory staff, outbreak responders, and individuals in or adjacent to epidemic regions.

cdc.gov
Zaire ebolavirus vaccination is an active immunization indication directed at the prevention of Ebola virus disease caused specifically by the filovirus species *Zaire ebolavirus* (also classified as *Orthoebolavirus zairense*) Immunization is indicated for individuals at high risk of exposure, including healthcare personnel, laboratory staff, outbreak responders, and individuals in or adjacent to epidemic regions
who.int
Zaire ebolavirus vaccination is an active immunization indication directed at the prevention of Ebola virus disease caused specifically by the filovirus species *Zaire ebolavirus* (also classified as *Orthoebolavirus zairense*) The target pathogen causes a severe, high-mortality viral hemorrhagic fever characterized by systemic immune dysregulation, extensive vascular endothelial damage, microvascular permeability, and consumptive coagulopathy
cdc.gov
The target pathogen causes a severe, high-mortality viral hemorrhagic fever characterized by systemic immune dysregulation, extensive vascular endothelial damage, microvascular permeability, and consumptive coagulopathy Immunization is indicated for individuals at high risk of exposure, including healthcare personnel, laboratory staff, outbreak responders, and individuals in or adjacent to epidemic regions
nm.org
The target pathogen causes a severe, high-mortality viral hemorrhagic fever characterized by systemic immune dysregulation, extensive vascular endothelial damage, microvascular permeability, and consumptive coagulopathy Clinical manifestations progress rapidly from acute flu-like symptoms to gastrointestinal distress, hypotension, severe multisystem organ failure, and hemorrhagic shock
clevelandclinic.org
Clinical manifestations progress rapidly from acute flu-like symptoms to gastrointestinal distress, hypotension, severe multisystem organ failure, and hemorrhagic shock
osha.gov
Immunization is indicated for individuals at high risk of exposure, including healthcare personnel, laboratory staff, outbreak responders, and individuals in or adjacent to epidemic regions

Personalize your experience

Follow Zaire ebolavirus vaccination and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it